Trading Plan: Can Nifty 50, Bank Nifty break previous day’s high on Muhurat Trading?

The Nifty 50 index is expected to face resistance at the 25,900–26,000 zone on the Muhurat Trading day, while support is ...
Targeted Oncology

DESTINY-Breast11: Neoadjuvant T-DXd/THP Improves pCR in High-Risk HER2+ BC

“DESTINY-Breast11 results support T-DXd [plus] THP as a more effective and less toxic neoadjuvant treatment compared with ddAC-THP, and it may become the preferred regimen for patients with high-risk, ...
CURE

Presurgical Enhertu Combo Elicits Response Benefit in HER2+ Early Breast Cancer

Neoadjuvant Enhertu then THP improved pathological complete response rate in patients with high-risk, HER2-positive early ...
CURE

Imfinzi Plus Chemo Improves Survival in G/GEJ Adenocarcinoma

Imfinzi plus FLOT chemotherapy significantly improves overall survival in resectable G/GEJ adenocarcinoma compared to placebo ...